BECTON, DICKINSON AND COMPANY Business Combination, Consideration Transferred, Equity Interests Issued and Issuable
BECTON, DICKINSON AND COMPANY (BDX) reported Business Combination, Consideration Transferred, Equity Interests Issued and Issuable of $0 for the 12-month period ending 2020-09-30, per its 10-K filed 2020-11-25.
Discontinued › Notes › Business Combinations › Business Combination, Asset Acquisition, Transaction between Entities under Common Control, and Joint Venture Formation
us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable · last filed 2020-11-25
- BECTON, DICKINSON AND COMPANY business combination, consideration transferred, equity interests issued and issuable for the quarter ending 2019-09-30 was $0.00.
- BECTON, DICKINSON AND COMPANY business combination, consideration transferred, equity interests issued and issuable for the quarter ending 2019-06-30 was $0.00.
- BECTON, DICKINSON AND COMPANY business combination, consideration transferred, equity interests issued and issuable for the quarter ending 2019-03-31 was $0.00.
- BECTON, DICKINSON AND COMPANY business combination, consideration transferred, equity interests issued and issuable for the quarter ending 2018-12-31 was $0.00, a 100.00% decline year-over-year.
- BECTON, DICKINSON AND COMPANY business combination, consideration transferred, equity interests issued and issuable for fiscal 2020 was $0.00.
- BECTON, DICKINSON AND COMPANY business combination, consideration transferred, equity interests issued and issuable for fiscal 2019 was $0.00, a 100.00% decline from fiscal 2018.
- BECTON, DICKINSON AND COMPANY business combination, consideration transferred, equity interests issued and issuable for fiscal 2018 was $8.00B.
- BECTON, DICKINSON AND COMPANY business combination, consideration transferred, equity interests issued and issuable for fiscal 2017 was $0.00.
| Period end | Business Combination, Consideration Transferred, Equity Interests Issued and Issuable 3 month | Business Combination, Consideration Transferred, Equity Interests Issued and Issuable 6 month | Business Combination, Consideration Transferred, Equity Interests Issued and Issuable 9 month | Business Combination, Consideration Transferred, Equity Interests Issued and Issuable 12 month |
|---|---|---|---|---|
| 2020-09-30 | $0.00 10-K · filed 2020-11-25 | |||
| 2019-09-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-11-25 | $0.00 derived: sum of 2 quarters · filed 2020-11-25 | $0.00 derived: sum of 3 quarters · filed 2020-11-25 | $0.00 10-K · filed 2020-11-25 |
| 2019-06-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-08-06 | $0.00 derived: sum of 2 quarters · filed 2019-08-06 | $0.00 10-Q · filed 2019-08-06 | $0.00 derived: sum of 4 quarters · filed 2020-11-25 |
| 2019-03-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-05-09 | $0.00 10-Q · filed 2019-05-09 | $0.00 derived: sum of 3 quarters · filed 2020-11-25 | $0.00 derived: sum of 4 quarters · filed 2020-11-25 |
| 2018-12-31 | $0.00 10-Q · filed 2019-02-05 | $0.00 derived: sum of 2 quarters · filed 2020-11-25 | $0.00 derived: sum of 3 quarters · filed 2020-11-25 | $0.00 derived: sum of 4 quarters · filed 2020-11-25 |
| 2018-09-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-11-25 | $0.00 derived: sum of 2 quarters · filed 2020-11-25 | $0.00 derived: sum of 3 quarters · filed 2020-11-25 | $8.00B 10-K · filed 2020-11-25 |
| 2018-06-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-08-06 | $0.00 derived: sum of 2 quarters · filed 2019-08-06 | $8.00B 10-Q · filed 2019-08-06 | $8.00B derived: sum of 4 quarters · filed 2019-11-27 |
| 2018-03-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-05-09 | $8.00B 10-Q · filed 2019-05-09 | $8.00B derived: sum of 3 quarters · filed 2019-11-27 | $8.00B derived: sum of 4 quarters · filed 2019-11-27 |
| 2017-12-31 | $8.00B 10-Q · filed 2019-02-05 | $8.00B derived: sum of 2 quarters · filed 2019-11-27 | $8.00B derived: sum of 3 quarters · filed 2019-11-27 | |
| 2017-09-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-11-27 | $0.00 derived: sum of 2 quarters · filed 2019-11-27 | $0.00 10-K · filed 2019-11-27 | |
| 2017-06-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-08-02 | $0.00 10-Q · filed 2018-08-02 | ||
| 2017-03-31 | $0.00 10-Q · filed 2018-05-03 | |||
| 2016-09-30 | $0.00 10-K · filed 2018-11-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| BOSTON SCIENTIFIC CORP (BSX) | United States | $64.781B | 17.29 |
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| 3M CO (MMM) | United States | $86.404B | 27.87 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |